Now looking like recruitment pre YE. Think they are seeking 100 HU intolerant/resistant and will compare with best in class.
This article from 2017
sheffield.ac.uk/news/nr/blo...
Exciting because if successful, can be rolled out quickly and cheaply. Been in use since 1940 and in very low dose (for rheumatoid arthritis) since 1980’s.
Surprised taking so long to fund roll out though? Perhaps because generic.